Epidemiological study of adverse events following immunization in under 5 year children
Background: The present study was conducted to study the socioeconomic and the demographic profile of children reporting with adverse events following immunization (AEFI) along with the determinants associated with AEFIs, based on investigation of each case and to assess the proportion of programmat...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2021;volume=10;issue=7;spage=2482;epage=2487;aulast=Pagar |
id |
doaj-69ce26d744d640ca9065a4c658e2dd17 |
---|---|
record_format |
Article |
spelling |
doaj-69ce26d744d640ca9065a4c658e2dd172021-08-09T09:56:23ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632021-01-011072482248710.4103/jfmpc.jfmpc_2328_20Epidemiological study of adverse events following immunization in under 5 year childrenVikrant S PagarSushant S ChavanSarika P PatilAnant BordeAmol D KingeNaveen KhargekarBackground: The present study was conducted to study the socioeconomic and the demographic profile of children reporting with adverse events following immunization (AEFI) along with the determinants associated with AEFIs, based on investigation of each case and to assess the proportion of programmatic errors linked with AEFI cases. Materials and Methods: Record-based cross–sectional study conducted among sample of 118 cases of AEFI were reported. The case reports of all AEFI cases were procured and analyzed to identify factors associated with reported AEFI. The questionnaires related with preliminary investigation reports (PIRs) including forensic evidence of death cases were analyzed. Percentage analysis of data was done by proportions, measures of central tendencies, and Chi-square test. Results: Most of the cases reported were between 0 and 3 months of age constituting 39%. AEFI was seen more in male child than female. more than half of cases of AEFI were recorded following immunization with OPV/DPT/HBV together (66.94%). Most common AEFI reported were convulsion (68.64 %) and fever (58.47%) followed by local swelling at site of injection (11.86%). More than half of the cases of AEFI occurred within 12 hours of immunization (61.88%). Birth weight of most cases of AEFI were in the range between 2 and 2.4 kg (44.06%), followed by range between 2.5 and 2.9 kg (32.20%), the mean of birth weight was 2.51 kg. Conclusion: Convulsion was the most commonly reported AEFI, majority of AEFI occur within 12 h of immunization. Most of the AEFI were recorded following immunization with OPV/DPT/HBV together.http://www.jfmpc.com/article.asp?issn=2249-4863;year=2021;volume=10;issue=7;spage=2482;epage=2487;aulast=Pagaraefiimmunization |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vikrant S Pagar Sushant S Chavan Sarika P Patil Anant Borde Amol D Kinge Naveen Khargekar |
spellingShingle |
Vikrant S Pagar Sushant S Chavan Sarika P Patil Anant Borde Amol D Kinge Naveen Khargekar Epidemiological study of adverse events following immunization in under 5 year children Journal of Family Medicine and Primary Care aefi immunization |
author_facet |
Vikrant S Pagar Sushant S Chavan Sarika P Patil Anant Borde Amol D Kinge Naveen Khargekar |
author_sort |
Vikrant S Pagar |
title |
Epidemiological study of adverse events following immunization in under 5 year children |
title_short |
Epidemiological study of adverse events following immunization in under 5 year children |
title_full |
Epidemiological study of adverse events following immunization in under 5 year children |
title_fullStr |
Epidemiological study of adverse events following immunization in under 5 year children |
title_full_unstemmed |
Epidemiological study of adverse events following immunization in under 5 year children |
title_sort |
epidemiological study of adverse events following immunization in under 5 year children |
publisher |
Wolters Kluwer Medknow Publications |
series |
Journal of Family Medicine and Primary Care |
issn |
2249-4863 |
publishDate |
2021-01-01 |
description |
Background: The present study was conducted to study the socioeconomic and the demographic profile of children reporting with adverse events following immunization (AEFI) along with the determinants associated with AEFIs, based on investigation of each case and to assess the proportion of programmatic errors linked with AEFI cases. Materials and Methods: Record-based cross–sectional study conducted among sample of 118 cases of AEFI were reported. The case reports of all AEFI cases were procured and analyzed to identify factors associated with reported AEFI. The questionnaires related with preliminary investigation reports (PIRs) including forensic evidence of death cases were analyzed. Percentage analysis of data was done by proportions, measures of central tendencies, and Chi-square test. Results: Most of the cases reported were between 0 and 3 months of age constituting 39%. AEFI was seen more in male child than female. more than half of cases of AEFI were recorded following immunization with OPV/DPT/HBV together (66.94%). Most common AEFI reported were convulsion (68.64 %) and fever (58.47%) followed by local swelling at site of injection (11.86%). More than half of the cases of AEFI occurred within 12 hours of immunization (61.88%). Birth weight of most cases of AEFI were in the range between 2 and 2.4 kg (44.06%), followed by range between 2.5 and 2.9 kg (32.20%), the mean of birth weight was 2.51 kg. Conclusion: Convulsion was the most commonly reported AEFI, majority of AEFI occur within 12 h of immunization. Most of the AEFI were recorded following immunization with OPV/DPT/HBV together. |
topic |
aefi immunization |
url |
http://www.jfmpc.com/article.asp?issn=2249-4863;year=2021;volume=10;issue=7;spage=2482;epage=2487;aulast=Pagar |
work_keys_str_mv |
AT vikrantspagar epidemiologicalstudyofadverseeventsfollowingimmunizationinunder5yearchildren AT sushantschavan epidemiologicalstudyofadverseeventsfollowingimmunizationinunder5yearchildren AT sarikappatil epidemiologicalstudyofadverseeventsfollowingimmunizationinunder5yearchildren AT anantborde epidemiologicalstudyofadverseeventsfollowingimmunizationinunder5yearchildren AT amoldkinge epidemiologicalstudyofadverseeventsfollowingimmunizationinunder5yearchildren AT naveenkhargekar epidemiologicalstudyofadverseeventsfollowingimmunizationinunder5yearchildren |
_version_ |
1721214383338553344 |